Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Shen_2022_Drug.Metab.dispos__

Reference

Title: The Covid-19 oral drug Molnupiravir is a CES2 substrate: potential drug-drug interactions and impact of CES2 genetic polymorphism in vitro
Shen Y, Eades W, Liu W, Yan B
Ref: Drug Metabolism & Disposition: The Biological Fate of Chemicals, :, 2022 : PubMed

        



Related information

Substrate | Molnupiravir,


Citations formats

Shen Y, Eades W, Liu W, Yan B (2022)
The Covid-19 oral drug Molnupiravir is a CES2 substrate: potential drug-drug interactions and impact of CES2 genetic polymorphism in vitro
Drug Metabolism & Disposition: The Biological Fate of Chemicals

Shen Y, Eades W, Liu W, Yan B (2022)
Drug Metabolism & Disposition: The Biological Fate of Chemicals



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer